# Amaranth Oil for Dermatologic Conditions: Inflammation Control and Cytotoxicity Assessment in Skin-Related Cell Models—Preliminary Study

**Authors:** Paweł Paśko, Agnieszka Galanty, Ewelina Prochownik, Alma Leticia Martinez-Ayala, Alma Chu-Martínez, Pitipong Thobunluepop, Danail Pavlov, Aviva Friedman-Ezra, Shela Gorinstein

PMC · DOI: 10.3390/molecules31060968 · Molecules · 2026-03-13

## TL;DR

This study shows that amaranth oil, especially when enriched with rose oil, can reduce inflammation and selectively kill cancer cells in skin models, suggesting potential for treating skin diseases.

## Contribution

The study introduces a rose oil-enriched amaranth oil formulation with enhanced anti-inflammatory and selective cytotoxic effects in skin-related models.

## Key findings

- AMOR reduced IL-6, IL-1β, and TNF-α release more effectively than AMO in inflammation models.
- AMOR showed selective cytotoxicity to melanoma cells with IC50 values of 3.8 μg/mL and 18.9 μg/mL for A375 and HTB140, respectively.
- AMOR demonstrated stronger albumin-binding interactions, potentially improving delivery and retention in tissues.

## Abstract

Amaranth oil (AMO) and its topical formulation enriched with rose oil (AMOR) were evaluated for anti-inflammatory and cytotoxic properties in skin-relevant models. Two complementary inflammation models were used to assess immunomodulatory potential, (i) LPS-stimulated macrophages and (ii) TNF-α/IFN-γ-stimulated immortalized HaCaT keratinocytes, while cytotoxicity and selectivity were tested on human HaCaT keratinocytes and melanoma cell lines (A375, HTB140). GC-MS and FTIR analyses were performed to confirm the presence of key bioactive compounds (squalene, fatty acids, phenolics). AMOR showed significantly higher polyphenol and palmitic acid content than AMO. In both inflammation models, AMOR more effectively reduced IL-6, IL-1β, and TNF-α release. Cytotoxicity assays revealed that both oils were safe for normal keratinocytes, while selectively cytotoxic to melanoma cells, with AMOR demonstrating greater potency (IC50 A375 = 3.8 μg/mL and HTB140 = 18.9 μg/mL). Albumin-binding studies showed that AMOR had stronger interactions with these proteins, which may enhance delivery and tissue retention. In conclusion, both oils exhibit promising topical safety, but AMOR provides enhanced anti-inflammatory and cytotoxic effects due to its enriched composition. This study supports the therapeutic potential of amaranth oil in different skin diseases, especially when combined with essential oils of complementary bioactivity.

## Linked entities

- **Proteins:** LOC100189571 (uncharacterized LOC100189571)
- **Chemicals:** squalene (PubChem CID 638072), fatty acids (PubChem CID 264), palmitic acid (PubChem CID 985), IL-6 (PubChem CID 165368475)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** melanoma (MESH:D008545), Dermatologic Conditions (MESH:D000168), Cytotoxicity (MESH:D064420), skin diseases (MESH:D012871), Inflammation (MESH:D007249)
- **Chemicals:** A375 (-), squalene (MESH:D013185), palmitic acid (MESH:D019308), oils (MESH:D009821), fatty acids (MESH:D005227), LPS (MESH:D008070), polyphenol (MESH:D059808), essential oils (MESH:D009822)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029062/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029062/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029062/full.md

---
Source: https://tomesphere.com/paper/PMC13029062